Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-04

Clinical Trial Update: Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update on treating intracerebral hemorrhage in patients taking non-vitamin K antagonist oral anticoagulants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Intracerebral Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED